Stock Events

Stock Events

Unibios. 

€2.39
0
+€0.11+4.82% Wednesday 06:02

Statistics

Day High
2.39
Day Low
2.39
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
41.08M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Oct 25
€0.03
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Financials

6.97%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
29.44MRevenue
2.05MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BEXQ.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with Unibios in the development and marketing of medications and vaccines for various diseases.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a leading pharmaceutical company that competes with Unibios in the research, development, manufacturing, and marketing of a wide range of health solutions.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a multinational corporation that operates in the pharmaceutical, medical devices, and consumer goods sectors, competing with Unibios in the healthcare and pharmaceuticals market.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a global healthcare company that competes with Unibios in the pharmaceutical and vaccines sectors, focusing on a wide array of diseases.
Novartis
NVS
Mkt Cap237.61B
Novartis AG is a Swiss multinational pharmaceutical company that competes with Unibios in developing and marketing drugs in various therapeutic areas.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global biopharmaceutical company focused on human health, competing with Unibios in the development of pharmaceuticals and vaccines.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a biopharmaceutical company that competes with Unibios in the discovery, development, and commercialization of a broad range of pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Unibios in the research and development of innovative medicines.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a Swiss multinational healthcare company that competes with Unibios in the pharmaceutical and diagnostics industries.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Unibios in the discovery, development, and commercialization of prescription medicines.

About

Unibios Holdings S.A., through its subsidiaries, develops and installs water treatment and recycling systems in Europe, Africa, and the Middle East. It also offers heating and air conditioning equipment, as well as installs and rents facade scaffoldings. The company was formerly known as Biossol SA and changed its name to Unibios Holdings S.A. in July 2008. Unibios Holdings S.A. was founded in 1940 and is based in Ano Liosia, Greece.
Show more...
CEO
ISIN
GRS084003011
WKN
000A2DLWW

Listings

LSE
GB
0RMW.LSE
AT
GR
BIOSK.AT
F
DE
BEXQ.F

0 Comments

Share your thoughts

FAQ

What is Unibios. stock price today?▼
The current price of BEXQ.F is €2.39 EUR — it has increased by +4.82% in the past 24 hours. Watch Unibios. stock price performance more closely on the chart.
What is Unibios. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Unibios. stocks are traded under the ticker BEXQ.F.
What is Unibios. market cap?▼
Today Unibios. has the market capitalization of 41.08M
What is Unibios. revenue for the last year?▼
Unibios. revenue for the last year amounts to 29.44M EUR.
What is Unibios. net income for the last year?▼
BEXQ.F net income for the last year is 2.05M EUR.
Does Unibios. pay dividends?▼
Yes, BEXQ.F dividends are paid en. The last dividend per share was 0.03 EUR. As of today, Dividend Yield (FWD)% is 0%.
When did Unibios. complete a stock split?▼
Unibios. has not had any recent stock splits.